This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (22)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Leo E. Hollister, MD; John J. Prusmack, MD

Arch Gen Psychiatry. 1974;31(5):695-698.

Abstract
We used three different studies involving patients undergoing detoxification to evaluate the worth of propranolol hydrochloride in withdrawal of opiates. If propranolol acts as a narcotic antagonist, the patient's condition should become worse and require increased methadone hydrochloride; if it were to afford symptomatic relief by blocking autonomic responses, methadone requirements might be decreased. None of the studies indicated that propranolol hydrochloride in doses of 160 mg/day or less aggravated withdrawal symptoms. Patients treated with the drug consistently required a somewhat smaller methadone dose for detoxification. Patients who responded favorably had mild withdrawal symptoms. The small benefit from the drug hardly merits its consideration as an adjunct to the treatment of withdrawal from opiates.

Author Affiliations
From the Veterans Administration Hospital and Department of Psychiatry, Stanford University School of Medicine, Palo Alto, Calif.

Footnotes
Accepted for publication July 18, 1974.

Reprint requests to the Veterans Administration Hospital, 3801 Miranda Ave, Palo Alto, CA 94304 (Dr. Hollister).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of Propranolol in Opiate Dependence
Resnick et al.
Arch Gen Psychiatry 1976;33:993-997.
ABSTRACT